KeyBanc lowered the firm’s price target on Acadia Healthcare (ACHC) to $35 from $55 and keeps an Overweight rating on the shares. The firm expects a miss/lower given softer Q3 volumes; investors will be focused on a potential takeout/strategic alternatives. KeyBanc thinks $30-$40/share is a reasonable range in a takeout.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC: